Clear or slightly opalescent liquid contained within colorless and transparent prefilled syringe.
Influenza virus surface antigens (hemagglutinin and neuraminidase)*, inactivated, of the following strains: [A/Victoria/4897/2022, IVR-238 (H1N1)] 15 μg HA**, [A/Croatia/10136RV/2023 (NYMC X-425A) (H3N2)] 15 μg HA**, [B/Michigan/01/2021] 15 μg HA**, [B/Phuket/3073/2013] 15 μg HA** per 0.5 mL dose.
*propagated in Madin Darby Canine Kidney (MDCK) cells.
**hemagglutinin.
The vaccine complies with the WHO recommendation (southern hemisphere) for the 2025 season.
Excipients/Inactive Ingredients: Sodium chloride, Potassium chloride, Potassium dihydrogen phosphate, Disodium phosphate dihydrate, Magnesium chloride hexahydrate, Calcium chloride dihydrate, Water for injection.
Other Services
Country
Account